Readout of Phase 3 Semaglutide Trials Marks Critical Moment in Alzheimer’s Research and Suggests Potential for Combination Therapies

Data provides new insights into targeting the diverse pathobiology of Alzheimer’s disease, an approach spearheaded by the ADDF NEW YORK, Nov. 24, 2025 /PRNewswire/ — Today, Novo Nordisk released topline results from their phase 3 Evoke and Evoke+ trials of semaglutide, an oral GLP-1…
Novo Nordisk Shares Slump After Ozempic Pill Fails in Alzheimer’s Trials – The Wall Street Journal

Novo Nordisk Shares Slump After Ozempic Pill Fails in Alzheimer’s Trials The Wall Street JournalView Full Coverage on Google News
Ozempic Pill Flops in Major Trials for Alzheimer’s

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease’s progression compared to a placebo.
The complicated relationship between GLP-1s and pregnancy

A new study sheds light on the risks and benefits of taking GLP-1 weight-loss drugs before having a baby.
STAT+: Lilly hits trillion-dollar valuation as GLP-1 era peaks

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! We’re closing in on CMS’s deadline for 2027 Medicare-negotiated drug prices. Plus, we see a break from precedent in how the FDA selects priority review vouchers, and more. Can a GLP-1 drug slow Alzheimer’s […]
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in

Eli Lilly LLY briefly crossed the $1 trillion market cap on Nov. 21, 2025 — becoming the first-ever health-care company to join the elite group mainly dominated by tech giants, as mentioned on CNBC. Shares touched around $1,059 on the day. GLP-1 &GIP Leadership Fuels Rally The stock has surged 36.2% this year, mainly backed by […]
Thinking about weight-loss jabs but fear the side effects? Try these miracle foods dubbed ‘nature’s Ozempic’ that produce GLP-1 BEFORE you book that telehealth appointment

‘What if I told you that you can introduce foods into your diet that help the body increase its natural production of GLP-1? Foods you can enjoy that have no side effects …’
NVO US

NVO US Novo Nordisk A/S Sponsored ADR Class B BATS:NVO A3MInvestments The decline in Novo Nordisk shares is not the result of a single factor, but rather the result of a complex set of fundamental issues: weakening financial performance, loss of competitive advantage in key products, and increased strategic risks. While negative data on Eli […]
A Healthy Dose Of Competition Sends Weight-Loss Drug Prices Plummeting

Novo and Lilly just slashed prices on GLP-1 weight-loss drugs that recently cost over $1,000 a month. What happened?
Pharmalittle: We’re reading about failed Novo Alzheimer’s trials, favorable Bayer stroke results, and more

Good morning, Jason Mast here filling in for Ed. Happy turkey week to all. I, for one, have always detested that dry, tasteless bird. (It’s sides and brisket for me, followed by pecan pie.) So in their interest, I leave you with this story, from 2018, about the Ozark turkeys that fell from the sky. […]